David P Arnott, Age 58356 40Th Ave, San Mateo, CA 94403

David Arnott Phones & Addresses

356 40Th Ave, San Mateo, CA 94403 (650) 357-0937

724 Laurel Ave, San Mateo, CA 94401 (650) 342-0773

Charlottesville, VA

Work

Position: Executive, Administrative, and Managerial Occupations

Education

Degree: Associate degree or higher

Emails

Mentions for David P Arnott

Career records & work history

Lawyers & Attorneys

David Arnott Photo 1

David Arnott - Lawyer

Office:
MacRoberts LLP
Specialties:
Construction Law, Arbitration, Litigation
ISLN:
914954710
Admitted:
1993

Resumes & CV records

Resumes

David Arnott Photo 44

Senior Scientist At Genentech

Position:
Senior Scientist at Genentech
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Genentech
Senior Scientist
David Arnott Photo 45

Senior Scientist At Genentech

Location:
San Francisco Bay Area
Industry:
Biotechnology
David Arnott Photo 46

David Arnott

Location:
United States

Publications & IP owners

Wikipedia

David Arnott Photo 47

David Arnott

David Arnott is an American actor, screenwriter and musical composer living in Southern California. Among his credits, Arnott co-wrote The Last Action Hero,...

Us Patents

Microwave Assisted Deglycosylation Of Proteins For Molecular Weight Determination By Mass Spectrometry

US Patent:
8163518, Apr 24, 2012
Filed:
Apr 27, 2007
Appl. No.:
11/741490
Inventors:
David P. Arnott - San Mateo CA, US
Jennie Lill - Pacifica CA, US
Wendy N. Sandoval - San Francisco CA, US
Richard L. Vandlen - Hillsborough CA, US
Assignee:
Genetech, Inc. - South San Francisco CA
International Classification:
C12P 21/06
C12N 13/00
US Classification:
435 681, 4351732
Abstract:
Methods are presented for microwave assisted, enzymatic deglycosylation of proteins. The rate at which deglycosylation is achieved and without protein degradation facilitates rapid and accurate molecular weight determination by mass spectrometry.

Il-17A/F Heterologous Polypeptides And Therapeutic Uses Thereof

US Patent:
2006027, Nov 30, 2006
Filed:
Jun 2, 2004
Appl. No.:
10/860824
Inventors:
David Arnott - San Mateo CA, US
Austin Gurney - Belmont CA, US
Philip Hass - Moss Beach CA, US
James Lee - San Bruno CA, US
Yan Wu - Foster City CA, US
International Classification:
C07K 14/54
C07H 21/04
C12P 21/04
C07K 16/24
US Classification:
435069520, 435320100, 435325000, 530351000, 536023500, 530388230
Abstract:
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Il-17A/F Heterologous Polypeptides And Therapeutic Uses Thereof

US Patent:
2007016, Jul 12, 2007
Filed:
Nov 29, 2006
Appl. No.:
11/606192
Inventors:
David Arnott - San Mateo CA, US
Mercedesz Balazs - Hayward CA, US
Nico Ghilardi - Millbrae CA, US
Austin Gurney - San Francisco CA, US
Philip Hass - Moss Beach CA, US
Sarah Hymowitz - San Francisco CA, US
James Lee - San Bruno CA, US
Wenjun Ouyang - Foster City CA, US
Melissa Starovasnik - San Francisco CA, US
Yan Wu - Foster City CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 38/20
C07H 21/04
C12P 21/04
C07K 14/54
C07K 16/24
US Classification:
424085200, 435069520, 435320100, 435325000, 530351000, 536023500, 530388230
Abstract:
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Il-17A/F Heterologous Polypeptides And Therapeutic Uses Thereof

US Patent:
2008016, Jul 3, 2008
Filed:
Dec 10, 2007
Appl. No.:
11/953733
Inventors:
David P. Arnott - San Mateo CA, US
Austin L. Gurney - Belmont CA, US
Philip E. Hass - Moss Beach CA, US
James M. Lee - San Bruno CA, US
Yan Wu - Foster City CA, US
International Classification:
C07K 16/00
US Classification:
5303872, 5303879, 5303873
Abstract:
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Il-17A/F Heterologous Polypeptides And Therapeutic Uses Thereof

US Patent:
2011025, Oct 20, 2011
Filed:
Mar 2, 2011
Appl. No.:
13/039201
Inventors:
David P. Arnott - San Mateo CA, US
Mercedes Z. Balazs - Hayward CA, US
Nico Ghilardi - Millbrae CA, US
Austin L. Gurney - San Francisco CA, US
Philip E. Haas - Moss Beach CA, US
Sarah Hymowitz - San Francisco CA, US
James M. Lee - San Bruno CA, US
Wenjun Ouyang - Foster City CA, US
Melissa A. Starovasnik - San Francisco CA, US
Yan Wu - Foster City CA, US
International Classification:
A61K 39/395
A61P 7/06
A61P 7/02
A61P 13/12
A61P 25/00
A61P 1/00
A61P 17/00
A61P 17/06
A61P 11/06
A61P 37/06
A61P 19/02
A61P 31/14
US Classification:
4241331, 4241391
Abstract:
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Il-17A/F Heterologous Polypeptides And Therapeutic Uses Thereof

US Patent:
2011031, Dec 29, 2011
Filed:
Mar 30, 2011
Appl. No.:
13/076148
Inventors:
David P. Arnott - San Mateo CA, US
Austin L. Gumey - Belmont CA, US
Philip E. Hass - Moss Beach CA, US
James M. Lee - San Bruno CA, US
Yan Wu - Foster City CA, US
International Classification:
A61K 38/20
C12N 15/63
C12N 5/10
C12N 1/21
C12N 1/16
C07K 14/54
A61K 39/395
G01N 33/53
C12Q 1/02
C12Q 1/68
C12N 5/078
C12P 21/00
A61P 37/02
B65D 90/00
C07H 21/04
US Classification:
424 852, 536 235, 4353201, 435358, 43525233, 4352542, 435348, 435 6952, 530351, 4241581, 5303892, 5303881, 5303873, 436501, 435 29, 435 61, 435375, 435 696, 2064595
Abstract:
The present invention is directed to a novel naturally occurring human cytokine that is comprised of a heterodimer of interleukin-17 and interleukin-17F designated herein as interleukin 17A/F (IL-17A/F). Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, specific antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders and other inflammatory diseases.

Amazon

David Arnott Photo 48

Literatures In African Languages: Theoretical Issues And Sample Surveys

Author:
David Arnott, Adeboye Babalola, Zefaniasy Bemananjara, Aleksander Ferenc, Roger Hewitt, Gordon Innes, Joanna Mantel-Niecko, Rajmund Ohly, Nina Pawlak, Harold Scheub
Publisher:
Cambridge University Press / Wiedza Powszechna
Binding:
Paperback
Pages:
672
ISBN #:
8321404405
EAN Code:
9788321404400
Scarce first edition of 1500 copies published in Poland.Contents:Oral Literature; The Rise of Written Literatures in African Languages; Literature in Fula; Literatures in the Mande and Neighbouring Languages; Akan Folk Literature and the Beginnings of Writing in Twi; Yoruba Literature; Literature in...
David Arnott Photo 49

It's Not A Fair World

Author:
Harry Shearer, Tom Leopold
Publisher:
L.A. Theatre Works
Binding:
Audible Audio Edition
Harry Shearer's fantasy about a World's Fair held in Kansas City. Told in quick blackouts, it resembles a profane Simpsons episode. An L.A. Theatre Works full-cast performance featuring Fran Adams, David Arnott, Lewis Arquette, James Avery, Hank Azaria, Dan Castellaneta, Timothy Fall, David L. Lande...
David Arnott Photo 50

Last Action Hero: From The Story By Zak Penn And Adam Leff And The Screenplay By Shane Black And David Arnott

Author:
Steve Newman, Ed Marsh
Publisher:
Newmarket Press
Binding:
Paperback
Pages:
127
ISBN #:
1557041741
EAN Code:
9781557041746
Behind the scenes with Arnold Schwarzenegger and Last Action Hero. Over 40 photos in full color! Schwarzenegger is Jack Slater, the movies' greatest action hero. One day Slater's world gets shaken up when a magical ticket blasts his biggest fan,. eleven-year-old Danny Madigan (Austin O'Brien), out o...

Isbn (Books And Publications)

The Nominal And Verbal Systems Of Fula

Author:
David Whitehorn Arnott
ISBN #:
0198151276

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.